VNTA (VNTA) Stock Price & Analysis
VNTA (VNTA) rose 0.00% to USD 0.03 as of July 25, 2026 at 17:38 UTC, according to Nexqual real-time market data.
VNTA last closed at USD 0.03; the session ranged USD 0.03–0.04 on volume of 3,950 shares. Market capitalization is $1.77M, with a 52-week range of USD 0.02–0.09 (PNK). Source: Nexqual, July 25, 2026 at 17:38 UTC.
Key Statistics (as of July 25, 2026 at 17:38 UTC)
| Price | USD 0.03 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.03 |
| Open | USD 0.04 |
| Day Range | USD 0.03 – 0.04 |
| 52-Week Range | USD 0.02 – 0.09 |
| Volume | 3,950 shares |
| Market Cap | $1.77M |
| Exchange | PNK |
Technical Analysis (VNTA)
Nexqual's technical model rates VNTA "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 17:38 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 32.39 (neutral) |
| vs SMA50 | Below (USD 0.04) |
| MACD | -0.01 (negative) |
Analyst Ratings (VNTA)
Wall Street analysts rate VNTA "None", per Nexqual as of July 25, 2026 at 17:38 UTC.
| Consensus Rating | None |
|---|
Earnings (VNTA)
Source: Nexqual, July 25, 2026 at 17:38 UTC.
Financials & Fundamentals (VNTA)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.02 |
Source: Nexqual, July 25, 2026 at 17:38 UTC.
Financial Health Score (VNTA)
Nexqual rates VNTA's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 17:38 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — No data |
| Cash Flow | Weak — Operating cash flow -$54K |
| Efficiency | Mixed — No data |
Ownership (VNTA)
| Shares Outstanding | 53.78M |
|---|
Source: Nexqual, July 25, 2026 at 17:38 UTC.
Leadership (VNTA)
VNTA is led by Janne Christensen, Chief Executive Officer, President, Chief Financial Officer, Treasurer and Director, per Nexqual as of July 25, 2026 at 17:38 UTC.
| Chief Executive Officer, President, Chief Financial Officer, Treasurer and Director | Janne Christensen |
|---|---|
| Chief Operating Officer, Vice President and Executive Director | David Holsworth |
| Vice President of Administration & Human Resources | Marilyn Thom |
| Vice President of Sales and Marketing | Elliott Martin |
| Executive Director | Trevor Conn |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AOXG | Aoxing Pharmaceutical Company, | USD 0 | ▲ 0% |
| GSAC | GelStat Corp. | USD 0 | ▲ 0% |
| SYUP | ANBC, INC. | USD 0 | ▲ 0% |
| ANAS | Alternaturals, Inc. | USD 0.01 | ▲ 0% |
| PTOS | P2 Solar, Inc. | USD 0.01 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 17:38 UTC. This page is informational and not investment advice.